These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26782292)

  • 1. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
    Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
    Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Soddu S; Di Felice E; Cabras S; Castellanos ME; Atzori L; Faa G; Pilloni L
    Eur J Histochem; 2013 Feb; 57(1):e6. PubMed ID: 23549465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
    Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
    Kerschmann RL; McCalmont TH; LeBoit PE
    Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
    Vasiljević N; Andersson K; Bjelkenkrantz K; Kjellström C; Månsson H; Nilsson E; Landberg G; Dillner J; Forslund O
    Int J Cancer; 2009 May; 124(10):2361-6. PubMed ID: 19165861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiregulin overexpression results in rapidly growing keratinocytic tumors: an in vivo xenograft model of keratoacanthoma.
    Billings SD; Southall MD; Li T; Cook PW; Baldridge L; Moores WB; Spandau DF; Foley JG; Travers JB
    Am J Pathol; 2003 Dec; 163(6):2451-8. PubMed ID: 14633617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
    Biesterfeld S; Josef J
    Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
    Fraga GR; Chow P
    J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma.
    Lammoglia-Ordiales L; Toussaint-Caire S; Contreras-Barrera M; Fonte-Avalos V; Rodriguez-Carreón AA; Rivera-Macias S; Dominguez-Cherit J
    J Drugs Dermatol; 2013 Mar; 12(3):e53-8. PubMed ID: 23545927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification.
    Misago N; Inoue T; Koba S; Narisawa Y
    J Dermatol; 2013 Jun; 40(6):443-52. PubMed ID: 23414327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
    Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
    Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
    Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.
    Batinac T; Zamolo G; Jonjić N; Gruber F; Petrovecki M
    Tumori; 2004; 90(1):120-7. PubMed ID: 15143984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
    Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.
    Basta-Juzbasić A; Klenkar S; Jakić-Razumović J; Pasić A; Loncarić D
    Acta Dermatovenerol Croat; 2004; 12(4):251-6. PubMed ID: 15588557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC.
    Turan G; Altun E; Aslan F; Kulahci O
    Indian J Pathol Microbiol; 2019; 62(4):561-565. PubMed ID: 31611440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.